Eighteen.Efficacy and protection of anticoagulants in the avoidance of venous thromboembolism in individuals with acute cerebral hemorrhage: a meta-Assessment of controlled studies. Ximelagatran, a completely new low-molecular-body weight oral prodrug in the immediate thrombin inhibitor, has demonstrated precedence more than warfarin which might ensure it is the drug of choice https://sgvasculargrp.com/medical-condition/deep-vein-thrombosis/